Cardiorenal relationships in patients with type 2 diabetes mellitus: new data of the ADVANCE study

被引:0
|
作者
Shestakova, M., V [1 ,2 ]
机构
[1] FGU Endocrinol Res Ctr Rosmedtechnol, Moscow, Russia
[2] FGU Endocrinol Res Ctr Rosmedtechnol, Inst Diabet, Moscow, Russia
来源
DIABETES MELLITUS | 2009年 / 12卷 / 02期
关键词
diabetes mellitus; diabetic nephropathy; coronary heart disease; arterial hypertension;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:25 / 27
页数:3
相关论文
共 50 条
  • [21] Serum resistin and adiponectin relationships with glucometabolic control in patients with type 2 diabetes mellitus
    Al-Regaiey, Khalid A.
    Habib, Syed S.
    Al Dokhi, Laila
    Jammah, Anwar A.
    Subhan, Mohammad M.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2018, 146 (5-6) : 285 - 290
  • [22] Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus
    Ebara, Shigeyuki
    Marumo, Mikio
    Mukai, Jun
    Ohki, Makoto
    Uchida, Kagehiro
    Wakabayashi, Ichiro
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (02) : 200 - 205
  • [23] New dyslipemic phenotypes in patients with type 2 diabetes mellitus.
    Wägner, AM
    Calvo, F
    Castellvi, A
    Rigla, M
    Bonet, R
    Ordóñez, J
    Pérez, A
    DIABETOLOGIA, 1998, 41 : A346 - A346
  • [24] A New Generation of Agents for Treating Patients With Type 2 Diabetes Mellitus
    Langer, Eric S.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2007, 107
  • [25] EMPAGLIFLOZIN: A NEW TREATMENT OPTION FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Dailey, G. E.
    DRUGS OF TODAY, 2015, 51 (09) : 519 - 535
  • [26] A new era of pharmacological treatment of patients with type 2 diabetes mellitus
    Kashiwagi, Atsunori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 4P - 4P
  • [27] ADVANCE: breaking new ground in type 2 diabetes
    Chalmers, John
    Perkovic, Vlado
    Joshi, Rohina
    Patel, Anushka
    JOURNAL OF HYPERTENSION, 2006, 24 : S22 - S28
  • [28] ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk independently of baseline blood pressure
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (02): : 5 - 10
  • [29] Relationships of lipoprotein (a) with the metabolic syndrome in type 2 diabetes mellitus
    Liu, Yu
    Shi, Hong-Li
    Zhu, Xi-Xing
    Fudan University Journal of Medical Sciences, 2004, 31 (01): : 36 - 38
  • [30] Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2
    Doerhoefer, Lena
    Lammert, Alexander
    Krane, Vera
    Gorski, Mathias
    Banas, Bernhard
    Wanner, Christoph
    Kraemer, Bernhard K.
    Heid, Iris M.
    Boeger, Carsten A.
    BMC MEDICAL GENETICS, 2013, 14